RecruitingNCT06409052
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Sponsor
M.D. Anderson Cancer Center
Enrollment
45 participants
Start Date
Jun 25, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study collects information from women about their risk factors, lifestyle, and perspectives on endometrial (uterine) cancer to help develop better prevention and early detection strategies. It includes women with uterine cancer, those with abnormal bleeding, and women without these diagnoses.
**You may be eligible if...**
- You are a woman 18 years of age or older
- You are being seen at MD Anderson Cancer Center (Houston area)
- You have been diagnosed with endometrial cancer, abnormal uterine bleeding, or endometrial hyperplasia — or you have none of these conditions (all three groups are welcome)
- You can read, write, and speak English
**You may NOT be eligible if...**
- You are under 18 years old
- You are unwilling or unable to provide written informed consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALQualitative interviews
Interviews will be conducted for approximately 45-60 minutes
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06409052
Related Trials
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
NCT071162131 location
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
NCT07584161
ALPINE: Maintenance Letrozole/Abemaciclib
NCT063663476 locations
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT0458575077 locations
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT05640999114 locations